Recent outbreaks of severe hepatitis A virus infections in Vienna.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 23 06 2020
accepted: 26 08 2020
pubmed: 18 9 2020
medline: 24 7 2021
entrez: 17 9 2020
Statut: ppublish

Résumé

To explore the epidemiology and clinical course of hepatitis A virus (HAV) infections at the Vienna General Hospital. We retrospectively identified patients who were tested positive for HAV-IgM at the Vienna General Hospital form Q1/2008 to Q3/2018. Our definition of severe HAV infection was AST and/or ALT > 5 × above the upper limit of normal (ULN); and liver dysfunction as (i) hepatic encephalopathy or ammonia > 100 μmol/L, (ii) coagulopathy with INR > 1.5, or (iii) jaundice with bilirubin > 5 mg/dL. A total of 578 HAV-IgM (+) were identified, including 31 (5.4%) and 38 (6.6%) without and with liver dysfunction, respectively. A proportional increase in severe HAV cases with and without liver dysfunction occurred in 2016/2017 with (21.5% (vs. 8.0% in the years before; p < 0.001). Thirty-seven (53.6%) patients with severe HAV were hospitalized, 6 (9%) required ICU support, and one patient received liver transplantation within 30 days. Patients with severe HAV and liver dysfunction were more often male (60.5 vs. 43.1%, p = 0.055) and younger (31.5 vs. 63 years, p < 0.001) as compared with other HAV-IgM (+) cases. The observed increase of severe HAV infections in Vienna in 2017 among young males, coincided with a multinational HAV outbreak among MSM. Our data suggests a higher likelihood of severe courses of hepatitis A in MSM. Vaccination against HAV should be recommended for risk groups.

Identifiants

pubmed: 32940811
doi: 10.1007/s10096-020-04028-x
pii: 10.1007/s10096-020-04028-x
pmc: PMC7817601
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

335-344

Références

Hollinger FB TJ (1996) Hepatitis A virus. In: Fields Virology. Philadelphia: Lippincott-Raven. p 735–82.10.1007
Bianco E, Stroffolini T, Spada E, Szklo A, Marzolini F, Ragni P et al (2003) Case fatality rate of acute viral hepatitis in Italy: 1995–2000. An update. Dig Liver Dis [Internet] [cited 2020 10];35:404–8. https://linkinghub.elsevier.com/retrieve/pii/S1590865803001579 https://doi.org/10.1016/S1590-8658(03)00157-9
Wang H, Naghavi M, Allen C, Barber RM, Carter A, Casey DC et al (2016) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1459–1544. https://doi.org/10.1016/S0140-6736(16)31012-1
doi: 10.1016/S0140-6736(16)31012-1
Lednar WM, Lemon SM, Kirkpatrick JW, Redfield RR, Fields ML, Kelley PW (1985) Frequency of illness associated with epidemic hepatitis a virus infections in adults. Am J Epidemiol [Internet] [cited 2020 8];122:226–33. http://www.ncbi.nlm.nih.gov/pubmed/3860002 https://doi.org/10.1093/oxfordjournals.aje.a114093
Pischke, Sven WH (2020) Hepatitis A [Internet]. In: Mauss, Stefan Berg, Thomas, Rockstroh, Jürgen Sarrazin, Christoph, Wedemeyer H (eds) Hepatology – a clinical textbook. [cited 2020 10]. p 36–7. https://www.hepatologytextbook.com/
Chromy D, Mandorfer M, Bucsics T, Schwabl P, Scheiner B, Schmidbauer C et al (2019) High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patients. United Eur Gastroenterol J [Internet] [cited 2020 10];7:507–16. http://www.ncbi.nlm.nih.gov/pubmed/31065368 . https://doi.org/10.1177/2050640619835394
Koff RS, Hepatitis A (1998) Lancet 30(351):1643–1649. https://doi.org/10.1016/S0140-6736(98)01304-X
doi: 10.1016/S0140-6736(98)01304-X
Kroneman A, de Sousa R, Verhoef L, Koopmans MPG, Vennema H (2018) Usability of the international HAVNet hepatitis A virus database for geographical annotation, backtracing and outbreak detection. Eurosurveillance. https://doi.org/10.2807/1560-7917.ES.2018.23.37.1700802
Vaughan G, Goncalves Rossi LM, Forbi JC, de Paula VS, Purdy MA, Xia G et al (2014) Hepatitis A virus: host interactions, molecular epidemiology and evolution. Infect Genet Evol 21:227–243. https://doi.org/10.1016/j.meegid.2013.10.023
doi: 10.1016/j.meegid.2013.10.023 pubmed: 24200587
Brown GR, Persley K (2002) Hepatitis A epidemic in the elderly. South Med J. https://doi.org/10.1097/00007611-200295080-00010
Chen N-Y, Liu Z-H, Shie S-S, Chen T-H Wu T-S(2017) Clinical characteristics of acute hepatitis A outbreak in Taiwan, 2015–2016: observations from a tertiary medical center. BMC Infect Dis [Internet] [cited 2020 21];17:441. http://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-017-2555-x https://doi.org/10.1186/s12879-017-2555-x
Rezende G, Roque-Afonso AM, Samuel D, Gigou M, Nicand E, Ferre V et al (2003) Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology. https://doi.org/10.1053/jhep.2003.50366
(2012) WHO position paper on hepatitis A vaccines - June 2012. Wkly Epidemiol Rec 87:261–76
Adult Immunization Schedule by Vaccine and Age Group | CDC [Internet]. [cited 2020 8]; https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html#note-hepa
Beneka B, Fischer K, Holzmann H, Jean-Paul K, Wiedermann-Schmidt U Zwiauer K (2020) Impfplan Österreich 2020 [Internet]. https://www.sozialministerium.at/dam/jcr:a0cf83df-7c20-48ac-b024-e6015a45a753/200103_Impfplan_Österreich_2020_pdfUA.pdf
Übertragbare Krankheiten [Internet]. [cited 2020 8]; http://www.statistik.at/web_de/statistiken/menschen_und_gesellschaft/gesundheit/gesundheitszustand/uebertragbare_krankheiten/022361.html
ECDC (2016) Hepatitis A virus in the EU/EEA, 1975–2014 [Internet]. [cited 2020 8]. https://www.ecdc.europa.eu/en/publications-data/hepatitis-virus-eueea-1975-2014 https://doi.org/10.2900/60930
Carrillo-Santisteve P, Tavoschi L, Severi E, Bonfigli S, Edelstein M, Byström E et al (2017) Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review. Lancet Infect Dis 17:e306–e319. https://doi.org/10.1016/S1473-3099(17)30392-4
doi: 10.1016/S1473-3099(17)30392-4 pubmed: 28645862
Enkirch T, Eriksson R, Persson S, Schmid D, Aberle SW, Löf E et al (2018) Hepatitis a outbreak linked to imported frozen strawberries by sequencing, Sweden and Austria, June to September 2018. Eurosurveillance. https://doi.org/10.2807/1560-7917.ES.2018.23.41.1800528
Patricia N, Freidl Gudrun S, Williams Christopher J, Otilia M, Carmen V, Ana A, Ingrid F, Harry V, Kazim B, Lin NS, Michael E, Alison S-P, Niamh M, Jonathan D, Mirko F, Wenzel J M of the EHAOIT (2018) Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017. Euro Surveill 23. https://doi.org/10.2807/1560-7917.ES.2018.23.33.1700641
R Core Team (2019) R: A Language and Environment for Statistical Computing [Internet]. https://www.r-project.org/
Hadley Wickham, Romain François LH and KM (2018) dplyr: A Grammar of Data Manipulation [Internet]. https://cran.r-project.org/package=dplyr
Walker A (2019) openxlsx: Read, Write and Edit XLSX Files [Internet]. https://cran.r-project.org/package=openxlsx
Yoshida K (2019) tableone: Create “Table 1” to Describe Baseline Characteristics [Internet]. https://cran.r-project.org/package=tableone
Gust ID, Feinstone SM (1988) Hepatitis A, 1st edn. CRC Press Inc. https://doi.org/10.1201/9781351073172
Freidl GS, Sonder GJ, Bovée LP, Friesema IH, van Rijckevorsel GG, Ruijs WL et al (2017) Hepatitis a outbreak among men who have sex with men (MSM) predominantly linked with the EuroPride, the Netherlands, July 2016 to February 2017. Eurosurveillance. https://doi.org/10.2807/1560-7917.ES.2017.22.8.30468
Rivas V, Barrera A, Pino K, Núñez R, Caceres CJ, Lopez-Lastra M et al (2018) Hepatitis a outbreak since november 2016 affecting men who have sex with men (MSM) in Chile connected to the current outbreak in MSM in Europe, situation up to October 2017. Eurosurveillance [Internet] [cited 2020 21];23. https://pubmed.ncbi.nlm.nih.gov/29510780/ https://doi.org/10.2807/1560-7917.ES.2018.23.9.18-00060
Gozlan Y, Bar-Or I, Rakovsky A, Savion M, Amitai Z, Sheffer R et al (2017) Ongoing hepatitis A among men who have sex with men (MSM) linked to outbreaks in Europe in Tel Aviv area, Israel, December 2016–June 2017. Euro Surveill Bull Eur sur les Mal Transm = Eur Commun Dis Bull 22. https://doi.org/10.2807/1560-7917.ES.2017.22.29.30575
Ajmera V, Xia G, Vaughan G, Forbi JC, Ganova-Raeva LM, Khudyakov Y et al (2011) What factors determine the severity of hepatitis A-related acute liver failure? J Viral Hepat. https://doi.org/10.1111/j.1365-2893.2010.01410.x
Mackinney-Novelo I, Barahona-Garrido J, Castillo-Albarran F, Santiago-Hernández JJ, Méndez-Sánchez N, Uribe M et al (2012) Clinical course and management of acute hepatitis a infection in adults. Ann Hepatol 11:652–657. https://doi.org/10.1016/s1665-2681(19)31438-3
doi: 10.1016/s1665-2681(19)31438-3 pubmed: 22947525
Beyrer C, Baral SD, Van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL et al (2012) Global epidemiology of HIV infection in men who have sex with men. Lancet 380:367–377. https://doi.org/10.1016/S0140-6736(12)60821-6
doi: 10.1016/S0140-6736(12)60821-6 pubmed: 22819660 pmcid: 3805037
Lanford RE, Feng Z, Chavez D, Guerra B, Brasky KM, Zhou Y et al (2011) Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. Proc Natl Acad Sci U S A 108:11223–11228. https://doi.org/10.1073/pnas.1101939108

Auteurs

David Bauer (D)

Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Vienna HIV & Liver Study Group, Medical University of Vienna, Vienna, Austria.

Anna Farthofer (A)

Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

David Chromy (D)

Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Vienna HIV & Liver Study Group, Medical University of Vienna, Vienna, Austria.
Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Benedikt Simbrunner (B)

Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Vienna HIV & Liver Study Group, Medical University of Vienna, Vienna, Austria.

Lisa Steininger (L)

Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Vienna HIV & Liver Study Group, Medical University of Vienna, Vienna, Austria.

Caroline Schmidbauer (C)

Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Vienna HIV & Liver Study Group, Medical University of Vienna, Vienna, Austria.
Division of Gastroenterology and Hepatology, Department of Medicine II, Wilhelminenspital, Vienna, Austria.

Teresa Binter (T)

Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Vienna HIV & Liver Study Group, Medical University of Vienna, Vienna, Austria.

Michael Trauner (M)

Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Mattias Mandorfer (M)

Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Vienna HIV & Liver Study Group, Medical University of Vienna, Vienna, Austria.

Ralf Schmidt (R)

Institute of Clinical Virology, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Florian Mayer (F)

Institute of Clinical Virology, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Heidemarie Holzmann (H)

Department of Virology, Medical University of Vienna, Vienna, Austria.

Robert Strassl (R)

Institute of Clinical Virology, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Thomas Reiberger (T)

Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria. thomas.reiberger@medunwien.ac.at.
Vienna HIV & Liver Study Group, Medical University of Vienna, Vienna, Austria. thomas.reiberger@medunwien.ac.at.
Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria. thomas.reiberger@medunwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH